Table 2 Correlation between LAMC2 expression and ESCC clinical parameters
Clinical parameters | Low expression | High expression | P valuea |
---|---|---|---|
N = 32 | N = 32 |  | |
Age (years) | Â | Â | Â |
 <60 | 12 | 17 | 0.209 |
 >60 | 20 | 15 | |
Gender | Â | Â | Â |
 Male | 23 | 30 | 0.02* |
 Female | 9 | 2 | |
Differentiation grade | Â | Â | Â |
 Well/moderate | 30 | 25 | 0.072 |
 Poor | 2 | 7 | |
Primary tumor invasion depth | Â | Â | Â |
 T1/T2 | 20 | 13 | 0.08 |
 T3/T4 | 12 | 9 | |
Lymph node metastasis | Â | Â | Â |
 Negative | 23 | 15 | 0.042* |
 Positive | 9 | 17 | |
TNM stage | Â | Â | Â |
 I/II | 26 | 16 | 0.008** |
 III/IV | 6 | 16 | |
Smoking | Â | Â | Â |
 Yes | 18 | 24 | 0.114 |
 No | 14 | 8 | |
Drinking | Â | Â | Â |
 Yes | 21 | 24 | 0.412 |
 No | 11 | 8 |